ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004

Final Issue of 1981

December 11, 1981

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

Public Health Service: Blumenthal Declines White House Job

November 14, 1997